Vets trying to control coccidiosis in sheep, cattle and pigs now have a new weapon in their arsenal, according to pharmaceutical manufacturer Krka.
Tolracol is a 50mg/ml suspension of toltrazuril licensed for use in all three target species to prevent coccidiosis infections in youngstock on farms with a history of the disease, the company says.
A vital component
Krka’s head of sales and marketing Killian Gaffney said: “Coccidiosis can have a devastating impact on young animals, resulting in ill-thrift, weight loss and potentially death, making its prevention a vital component of herd or flock management.
“Importantly, this is a tri-licence single dose product which requires vet prescription. The involvement of the vet in prescribing coccidiostats is important as their use should be part of a whole management approach to prevention.”
According to Krka, Tolracol should be used ahead of the peak infection period on farms with a pre-existing coccidiosis problem. It is recommended for use in neonatal pigs at three to five days old, and as soon as required in calves and lambs.
The company said it is also launching a marketing campaign to supports vets selling Tolracol, and will launch a farmer education campaign shortly.